2014 Rheumatology Highlights From Boston*
  • Program Overview
    2014 Rheumatology Highlights From Boston*
    November 15-19, 2014 | Boston, Massachusetts
    Review highlights from the 2014 Boston rheumatology meeting in CCO’s Independent Conference Coverage, which includes clinical commentary, a Conference Report with embedded slides, and a downloadable slideset.
  • Featured content
    In these highlights from the ClinicalThought program, CCO’s expert faculty members describe how they tackle challenging clinical decisions in the settings of lupus, psoriatic arthritis, and spondyloarthritis.
  • Featured content
    Chad Deal, MD, explores the clinical significance of key studies in rheumatoid arthritis presented at the 2014 American College of Rheumatology Annual Meeting.
  • Research presented at the 2014 ACR annual meeting showed that targeting the IL-23/IL-17 axis in ankylosing spondylitis led to high ASAS20 responses, and the use of TNF inhibitors benefits patients with nonradiographic axial spondyloarthritis.
    Date Posted: 2/6/2015
  • Featured content
    The 2014 American College of Rheumatology annual meeting provided us with new and promising data on the safety and efficacy of current and investigational agents. How soon will we have new treatment options for patients with PsA?
    Date Posted: 2/6/2015
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

6 of 6 Shown
  • Learning Module

    Boston 2014: ClinicalThought

    In these highlights from the ClinicalThought program, CCO’s expert faculty members describe how they tackle challenging clinical decisions in the settings of lupus, psoriatic arthritis, and spondyloarthritis.
    Faculty: Daniel J. Wallace MD, Vinod Chandran MBBS, MD, DM, PhD, Atul Deodhar MD
    Released: 3/19/2015
  • Current Progress in Rheumatoid Arthritis

    In this downloadable slideset, Chad Deal, MD, explores the clinical significance of key studies in rheumatoid arthritis presented at the 2014 American College of Rheumatology Annual Meeting.
    Date Posted: 3/5/2015
  • Clinical Focus

    Current Progress in Rheumatoid Arthritis

    Chad Deal, MD, explores the clinical significance of key studies in rheumatoid arthritis presented at the 2014 American College of Rheumatology Annual Meeting.
    Faculty: Chad Deal MD
    Released: 3/5/2015
  • Progress in Treating Axial Spondyloarthritis: My Thoughts on Novel Therapeutic Agents

    Atul Deodhar MD - 2/6/2015 2 comments / Last Comment: 3/17/2017
    Research presented at the 2014 ACR annual meeting showed that targeting the IL-23/IL-17 axis in ankylosing spondylitis led to high ASAS20 responses, and the use of TNF inhibitors benefits patients with nonradiographic axial spondyloarthritis.
  • Post-ACR Update: New Developments That Could Affect Treatment of Psoriatic Arthritis

    Vinod Chandran MBBS, MD, DM, PhD - 2/6/2015 1 comment / Last Comment: 3/18/2015
    The 2014 American College of Rheumatology annual meeting provided us with new and promising data on the safety and efficacy of current and investigational agents. How soon will we have new treatment options for patients with PsA?
  • Systemic Lupus Erythematosus: Do These 2 Late-Breaking Plenary Oral Abstracts Represent Breakthroughs in Treatment?

    Daniel J. Wallace MD - 1/29/2015 1 comment / Last Comment: 3/18/2015
    Two phase II late-breaking plenary oral abstracts at ACR offered tantalizing suggestions that could inform a successful phase III effort. Other presentations of note focused on the importance of patient-reported outcomes and the intriguing potential of studying already approved drugs in SLE.
6 of 6 Shown
Show 0 More
Loading...